These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33089050)

  • 1. Drug-induced 'Torsade de Pointes' in a COVID-19 patient despite discontinuation of chloroquine. Importance of its long half-life: a case report.
    Semedo E; Kapel GF; van Opstal J; van Dessel PFHM
    Eur Heart J Case Rep; 2020 Oct; 4(FI1):1-5. PubMed ID: 33089050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
    Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloroquine-induced QTc prolongation in COVID-19 patients.
    van den Broek MPH; Möhlmann JE; Abeln BGS; Liebregts M; van Dijk VF; van de Garde EMW
    Neth Heart J; 2020 Jul; 28(7-8):406-409. PubMed ID: 32350818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring.
    Ramireddy A; Chugh H; Reinier K; Ebinger J; Park E; Thompson M; Cingolani E; Cheng S; Marban E; Albert CM; Chugh SS
    J Am Heart Assoc; 2020 Jun; 9(12):e017144. PubMed ID: 32463348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine.
    Sinkeler FS; Berger FA; Muntinga HJ; Jansen MMPM
    Neth Heart J; 2020 Jul; 28(7-8):418-423. PubMed ID: 32648153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QTc prolongation in patients with COVID-19: a retrospective chart review.
    Pornwattanakavee SP; Priksri W; Leelakanok N
    Transl Clin Pharmacol; 2021 Dec; 29(4):197-205. PubMed ID: 35024360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: A narrative review based on the study of case reports.
    Hancox JC; Hasnain M; Vieweg WV; Crouse EL; Baranchuk A
    Ther Adv Infect Dis; 2013 Oct; 1(5):155-65. PubMed ID: 25165550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study.
    Strauss DG; Vicente J; Johannesen L; Blinova K; Mason JW; Weeke P; Behr ER; Roden DM; Woosley R; Kosova G; Rosenberg MA; Newton-Cheh C
    Circulation; 2017 Apr; 135(14):1300-1310. PubMed ID: 28213480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative torsade de pointes: a systematic review of published case reports.
    Johnston J; Pal S; Nagele P
    Anesth Analg; 2013 Sep; 117(3):559-564. PubMed ID: 23744954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long QTc interval and torsade de pointes caused by fluconazole.
    Pham CP; de Feiter PW; van der Kuy PH; van Mook WN
    Ann Pharmacother; 2006; 40(7-8):1456-61. PubMed ID: 16849620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythromycin, QTc interval prolongation, and torsade de pointes: Case reports, major risk factors and illness severity.
    Hancox JC; Hasnain M; Vieweg WV; Gysel M; Methot M; Baranchuk A
    Ther Adv Infect Dis; 2014 Apr; 2(2):47-59. PubMed ID: 25165555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reckless administration of QT interval-prolonging agents in elderly patients with drug-induced torsade de pointes.
    Jackobson G; Carmel NN; Lotan D; Kremer A; Justo D
    Z Gerontol Geriatr; 2018 Jan; 51(1):41-47. PubMed ID: 27878411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Torsade de pointes during sevoflurane anesthesia and fluconazole infusion in a patient with long QT syndrome. A case report.
    Tacken MC; Bracke FA; Van Zundert AA
    Acta Anaesthesiol Belg; 2011; 62(2):105-8. PubMed ID: 21919379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin.
    Hsia BC; Greige N; Quiroz JA; Khokhar AS; Daily J; Di Biase L; Ferrick KJ; Fisher JD; Krumerman A
    J Interv Card Electrophysiol; 2020 Nov; 59(2):337-345. PubMed ID: 32654098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pause-dependent torsade de pointes following acute myocardial infarction: a variant of the acquired long QT syndrome.
    Halkin A; Roth A; Lurie I; Fish R; Belhassen B; Viskin S
    J Am Coll Cardiol; 2001 Oct; 38(4):1168-74. PubMed ID: 11583899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
    Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations.
    Carlsson L; Abrahamsson C; Andersson B; Duker G; Schiller-Linhardt G
    Cardiovasc Res; 1993 Dec; 27(12):2186-93. PubMed ID: 8313427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin.
    Cipriani A; Zorzi A; Ceccato D; Capone F; Parolin M; Donato F; Fioretto P; Pesavento R; Previato L; Maffei P; Saller A; Avogaro A; Sarais C; Gregori D; Iliceto S; Vettor R
    Int J Cardiol; 2020 Oct; 316():280-284. PubMed ID: 32439366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torsades de pointes associated with remdesivir treatment for COVID-19 pneumonia.
    Fung JS; Levitan M; Landry S; McIsaac S
    J Assoc Med Microbiol Infect Dis Can; 2023 Mar; 8(1):99-104. PubMed ID: 37008584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citalopram and the KCNE1 D85N variant: a case report on the implications of a genetic modifier.
    Marstrand P; Christensen AH; Bartels ED; Theilade J
    Eur Heart J Case Rep; 2018 Dec; 2(4):yty106. PubMed ID: 31020182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.